Abstract |
As part of a prospective acellular pertussis (ACP) vaccine efficacy trial, 5 serum samples were obtained, over an 18-month period, from 101 ACP- vaccine recipients and 99 control subjects, to assess ACP antibody response and decay. Immunoglobulin (Ig) G and IgA antibodies to pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN), and fimbriae 2/3 (FIM) were measured by enzyme-linked immunosorbant assay, and titers of agglutinin were determined. Of the subjects, 16%-19% had preimmunization values of antibodies to PT that were above the assay's limit of quantitation (LOQ); in contrast, 36%-63% of the subjects had preimmunization values of antibodies to FHA, PRN, or FIM that were above the LOQ. Substantial increases in titers of IgG and IgA antibodies to the 3 ACP antigens (PT, FHA, and PRN) were observed. Over the 18-months, the percent decay in IgG and IgA antibodies ranged from 56% to 73% and from 57% to 70%, respectively; the IgG antibody response and decay suggests that geometric mean titers likely remain above the LOQ for 2-9 years and above the threshold of detection for 4-13 years. These findings support the use of ACP booster immunizations for adolescents and adults, to provide sustained levels of antibody.
|
Authors | Thuan Le, James D Cherry, Swei-Ju Chang, Maria Deloria Knoll, Martin L Lee, Steve Barenkamp, David Bernstein, Robert Edelman, Kathryn M Edwards, David Greenberg, Wendy Keitel, John Treanor, Joel I Ward, APERT Study |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 190
Issue 3
Pg. 535-44
(Aug 01 2004)
ISSN: 0022-1899 [Print] United States |
PMID | 15243929
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies, Bacterial
- Antigens, Bacterial
- Immunoglobulin A
- Immunoglobulin M
- Pertussis Vaccine
|
Topics |
- Adolescent
- Adult
- Aged
- Antibodies, Bacterial
(blood)
- Antigens, Bacterial
(immunology)
- Bordetella pertussis
(immunology)
- Double-Blind Method
- Female
- Humans
- Immunoglobulin A
(blood)
- Immunoglobulin M
(blood)
- Male
- Middle Aged
- Pertussis Vaccine
(administration & dosage, immunology)
- Prospective Studies
- Time Factors
- Vaccination
- Whooping Cough
(immunology, prevention & control)
|